The Potential Role of Inflammation in Alzheimer’s Disease
Watch the full interview here: Alzheimer’s disease (AD) is the most common form of dementia, and causes a progressive decline in memory, language, executive and visuospatial function, personality and behaviour.1 For many years, there have been only four approved medications to improve cognition in patients with AD, but these only address the symptoms, and do not […]
A Potential New Alzheimer’s Treatment That May Function by Modulating the Gut Microbiota
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common form of dementia.1 It is characterized by two hallmark pathologies: the deposition of amyloid-β plaques and the neurofibrillary tangles of hyperphosphorylated tau.1 The clinical presentation of AD includes a progressive decline in two or more cognitive domains, which include memory, language, executive and visuospatial function, personality, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!